Our latest manuscript in #AJCO explores 🩸 & intra-tumor NLR as prognostic biomarkers in pts with R/M HNSCC treated w/ combined cetux + nivo 💉 journals.lww.com/amjclinicalonc… @MoffittNews @WinshipAtEmory @OSUCCC_James
Robin Park, MD
@rprobinpark
🇰🇷🇨🇦🇺🇸 Medical Oncologist @MoffittNews | H&N/Endocrine Oncology | Early Therapeutics Development
334 Following 339 Followers 291 Posts
Latest posts 5
✨Thrilled to be joining @MoffittNews! Will be starting as a H&N/Endocrine Oncologist with an early therapeutics development/translational research focus. Excited for what’s ahead!
✨Thrilled to be attending AACR-KCA 2024 in Seoul to present the long-term FU & biomarker results from our cetux/nivo trial in R/M HNSCC ✨ @MoffittResearch @MoffittNews 🔥Beyond grateful for the travel grant award @AACR 🙏
🔥Excited to see our review out in @MCT_AACR!✨ We highlight the unmet needs & emerging therapies in HPV- R/M HNSCC🎯Grateful for the mentorship & guidance from @CHChungMD✨@MoffittHemOnc @MoffittResearch aacrjournals.org/mct/article/do…
And thrilled to 👀 this work also just published 🔥Opportunity to work on this by Dr. Christine Chung 🙏 Check out 👉 Phase Ib trial of IRX-2 plus durvalumab in patients with R/M HNSCC. sciencedirect.com/science/articl… @MoffittHemOnc @DrKedarKirtane